Investigational drug boosts pregnancy rates in women undergoing IVF, ICSI

Learn about OXO-001, a non-hormonal drug that increases pregnancy rates in women undergoing IVF or ICSI by enhancing embryo implantation. Also in this episode: patients with type 2 diabetes taking GLP-1 receptor agonists have a lower risk of certain obesity-associated cancers compared to those on insulin, though no significant reduction compared to metformin. Finally, the third story highlights research showing that smoking accelerates cognitive decline in memory and fluency, except for smokers with otherwise healthy lifestyles, who experience similar decline rates to non-smokers.